Compensation Overview

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers.  The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

We are seeking a passionate and energetic individual with strong PKPD modeling background to be part of the Nonclinical Development and Clinical Pharmacology (NDCP) Organization. As a PKPD modeler to support the pharmacometrics functions in the department, you will:

• Establish population PK models to identify intrinsic and extrinsic factors that impact PK, and to guide dose/schedule optimization and recommended phase 2 dose/schedule (RP2Ds) selection.

• Perform model-based simulations to optimize dosing to inform trial designs and clinical outcomes. Ensure quality and integrity of modeling and simulation results.

Required Skills, Experience, and Education:

• A Ph.D. or Pharm.D. with a PKPD Modeling & Simulation background.

• Extensive hands-on experience using NONMEM modeling software is a must.

• Familiar with common PKPD/TGI models and able to write customized NONMEM models.

• Relevant work experience in pharmaceutical companies is preferred but not required. Recent PhD graduates with a good track record of PKPD M&S publications are encouraged to apply.

• Proficiency in R programming is desired.

• Able to take dynamically assigned pharmacometrics tasks and deliver the results in a timely manner.

• Excellent verbal and written communication skills, and ability to clearly convey complex concepts and findings to both non-specialist and specialist audiences.

• A critical thinker passionate team player and quick learner with high energy who thrives in a dynamic and fast-paced environment.

• Demonstrated experience and track record in clinical-stage drug development is a big plus but not required.

Preferred Skills:

• Have prior knowledge or familiarity with longitudinal model analysis (e.g. ctDNA and tumor shrinkage).

• Have prior knowledge or familiarity with ER analysis for oncology compounds.

• Familiar with data handling.

The expected salary range for this role is $120,000 to $158,000. An individual’s position within the range may be influenced by multiple factors, including skills and experience in role, overall performance, individual impact and contributions, tenure, and market dynamics. Base salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.

Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].

#LI-Hybrid  #LI-CT1